• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

促性腺激素释放激素激动剂治疗可降低卵巢子宫内膜异位囊肿患者的血清白细胞介素-6浓度。

Gonadotropin-releasing hormone agonist treatment reduced serum interleukin-6 concentrations in patients with ovarian endometriomas.

作者信息

Iwabe Tomio, Harada Tasuku, Sakamoto Yasuko, Iba Yumiko, Horie Sayako, Mitsunari Masahiro, Terakawa Naoki

机构信息

Department of Obstetrics and Gynecology, Tottori University School of Medicine, Nishimachi, Yonago, Japan.

出版信息

Fertil Steril. 2003 Aug;80(2):300-4. doi: 10.1016/s0015-0282(03)00609-5.

DOI:10.1016/s0015-0282(03)00609-5
PMID:12909491
Abstract

OBJECTIVE

To determine whether serum interleukin (IL)-6 can be measured in patients with ovarian endometriomas and whether these measurements are useful in managing this disease.

DESIGN

A controlled clinical study and an in vitro study.

SETTING

Department of Obstetrics and Gynecology, Tottori University, Japan.Twenty-two patients with ovarian endometriomas.

INTERVENTION(S): Laparoscopic cystectomy for ovarian endometriomas was performed. Gonadotropin-releasing hormone (GnRH) agonist was administered for 3 months in nine patients before laparoscopic surgery. Endometriotic stromal cells obtained from patients with endometriomas with or without GnRH agonist treatment were cultured.

MAIN OUTCOME MEASURES(S): IL-6 concentrations in serum or supernatant of the cell culture were measured using ELISA.

RESULTS

The serum concentration of IL-6 in patients with endometriomas was higher at the time of diagnosis than in those without endometriomas. Laparoscopic surgery significantly reduced serum levels of IL-6. Serum IL-6 concentrations also decreased after treatment with GnRH agonist. IL-6 production was attenuated in the endometriotic stromal cells obtained from patients with GnRH agonist treatment compared with patients without such treatment.

CONCLUSION(S): GnRH agonist treatment may decrease IL-6 production in endometriotic cells. Measurement of serum IL-6 concentrations may be of value in managing patients with endometriomas.

摘要

目的

确定卵巢子宫内膜异位囊肿患者血清白细胞介素(IL)-6是否可检测,以及这些检测结果对该疾病的治疗是否有用。

设计

一项对照临床研究和一项体外研究。

地点

日本鸟取大学妇产科。22例卵巢子宫内膜异位囊肿患者。

干预措施

对卵巢子宫内膜异位囊肿进行腹腔镜囊肿切除术。9例患者在腹腔镜手术前3个月给予促性腺激素释放激素(GnRH)激动剂。对接受或未接受GnRH激动剂治疗的子宫内膜异位囊肿患者获取的异位内膜间质细胞进行培养。

主要观察指标

采用酶联免疫吸附测定法(ELISA)检测细胞培养上清液或血清中的IL-6浓度。

结果

子宫内膜异位囊肿患者诊断时血清IL-6浓度高于无子宫内膜异位囊肿患者。腹腔镜手术显著降低了血清IL-6水平。GnRH激动剂治疗后血清IL-6浓度也降低。与未接受GnRH激动剂治疗的患者相比,接受GnRH激动剂治疗患者获取的异位内膜间质细胞中IL-6生成减弱。

结论

GnRH激动剂治疗可能会降低异位内膜细胞中IL-6的生成。检测血清IL-6浓度可能对子宫内膜异位囊肿患者的治疗有价值。

相似文献

1
Gonadotropin-releasing hormone agonist treatment reduced serum interleukin-6 concentrations in patients with ovarian endometriomas.促性腺激素释放激素激动剂治疗可降低卵巢子宫内膜异位囊肿患者的血清白细胞介素-6浓度。
Fertil Steril. 2003 Aug;80(2):300-4. doi: 10.1016/s0015-0282(03)00609-5.
2
Impact of GnRH agonist treatment on recurrence of ovarian endometriomas after conservative laparoscopic surgery.促性腺激素释放激素激动剂治疗对保守性腹腔镜手术后卵巢子宫内膜异位囊肿复发的影响。
Fertil Steril. 2009 Jan;91(1):40-5. doi: 10.1016/j.fertnstert.2007.11.027. Epub 2008 Apr 18.
3
Secretory leukocyte protease inhibitor in ovarian endometriomas following GnRH agonist therapy.GnRH激动剂治疗后卵巢子宫内膜异位囊肿中的分泌型白细胞蛋白酶抑制剂
Obstet Gynecol. 2001 Apr;97(4):561-6. doi: 10.1016/s0029-7844(00)01200-x.
4
Combined treatment of endometriosis. GnRH agonists and laparoscopic surgery.子宫内膜异位症的联合治疗。促性腺激素释放激素激动剂与腹腔镜手术。
J Reprod Med. 1998 Mar;43(3 Suppl):316-20.
5
Serum interleukin-8 levels are elevated in patients with ovarian endometrioma.卵巢子宫内膜异位囊肿患者血清白细胞介素-8水平升高。
Fertil Steril. 2008 Oct;90(4):994-9. doi: 10.1016/j.fertnstert.2007.07.1355. Epub 2008 Jul 16.
6
One-year follow-up of serum antimüllerian hormone levels in patients with cystectomy: are different sequential changes due to different mechanisms causing damage to the ovarian reserve?膀胱切除术患者血清抗苗勒管激素水平的 1 年随访:不同的序贯变化是否由于导致卵巢储备损伤的不同机制引起?
Fertil Steril. 2013 Aug;100(2):516-22.e3. doi: 10.1016/j.fertnstert.2013.03.032. Epub 2013 Apr 8.
7
Gonadotropin-releasing hormone analogues reduce the proliferation of endometrial stromal cells but not endometriotic cells.促性腺激素释放激素类似物可减少子宫内膜基质细胞的增殖,但不能减少异位细胞的增殖。
Gynecol Obstet Invest. 2013;75(1):9-15. doi: 10.1159/000343748. Epub 2012 Nov 8.
8
Laparoscopic management of ovarian endometriomas: a critical review of current practice.
Curr Opin Obstet Gynecol. 2000 Aug;12(4):309-15. doi: 10.1097/00001703-200008000-00008.
9
Surgical excision of ovarian endometriomas: Does it truly impair ovarian reserve? Long term anti-Müllerian hormone (AMH) changes after surgery.卵巢子宫内膜异位囊肿的手术切除:它真的会损害卵巢储备功能吗?手术后抗苗勒管激素(AMH)的长期变化。
J Obstet Gynaecol Res. 2015 Nov;41(11):1773-8. doi: 10.1111/jog.12830. Epub 2015 Sep 30.
10
Laparoscopic Surgery Combined with GnRH Agonist in Endometriosis.腹腔镜手术联合促性腺激素释放激素激动剂治疗子宫内膜异位症
J Coll Physicians Surg Pak. 2019 Apr;29(4):313-316. doi: 10.29271/jcpsp.2019.04.313.

引用本文的文献

1
Immune Dysregulation in Endometriomas: Implications for Inflammation.内异症中的免疫失调:炎症的影响。
Int J Mol Sci. 2024 Apr 28;25(9):4802. doi: 10.3390/ijms25094802.
2
Gene expression analysis in endometriosis: Immunopathology insights, transcription factors and therapeutic targets.子宫内膜异位症的基因表达分析:免疫病理学见解、转录因子和治疗靶点。
Front Immunol. 2022 Nov 30;13:1037504. doi: 10.3389/fimmu.2022.1037504. eCollection 2022.
3
Impact of perioperative use of GnRH agonist or dienogest on ovarian reserve after cystectomy for endometriomas: a randomized controlled trial.
内异症囊肿切除术围手术期使用 GnRH 激动剂或地诺孕素对卵巢储备功能的影响:一项随机对照试验。
Reprod Biol Endocrinol. 2021 Dec 6;19(1):179. doi: 10.1186/s12958-021-00866-2.
4
Matrix remodeling and endometriosis.基质重塑与子宫内膜异位症
Reprod Med Biol. 2005 May 3;4(2):93-99. doi: 10.1111/j.1447-0578.2005.00098.x. eCollection 2005 Jun.
5
Manual acupuncture plus usual care versus usual care alone in the treatment of endometriosis-related chronic pelvic pain: study protocol for a randomised controlled feasibility study.手针疗法联合常规护理与单纯常规护理治疗子宫内膜异位症相关性慢性盆腔疼痛:一项随机对照可行性研究的研究方案
Pilot Feasibility Stud. 2017 Jul 6;4:10. doi: 10.1186/s40814-017-0152-9. eCollection 2018.
6
A comparison between serum levels of interleukin-6 and CA125 in patients with endometriosis and normal women.子宫内膜异位症患者与正常女性血清白细胞介素-6水平和CA125水平的比较。
Med J Islam Repub Iran. 2015 Oct 19;29:280. eCollection 2015.
7
A pilot study to search possible mechanisms of ultralong gonadotropin-releasing hormone agonist therapy in IVF-ET patients with endometriosis.一项探索超长 GnRH 激动剂疗法在子宫内膜异位症患者 IVF-ET 中可能作用机制的初步研究。
J Ovarian Res. 2014 Oct 21;7:100. doi: 10.1186/s13048-014-0100-8.
8
Circulating levels of monocyte chemoattractant protein-1 and interleukin-7 in women who have undergone bilateral salpingo-oophorectomy.行双侧输卵管卵巢切除术的女性循环中单核细胞趋化蛋白-1 和白细胞介素-7 的水平。
J Inflamm Res. 2013 Dec 27;7:1-7. doi: 10.2147/JIR.S52728. eCollection 2013.
9
Immune interactions in endometriosis.子宫内膜异位症中的免疫相互作用。
Expert Rev Clin Immunol. 2011 Sep;7(5):611-26. doi: 10.1586/eci.11.53.
10
Peripheral biomarkers of endometriosis: a systematic review.子宫内膜异位症的外周生物标志物:系统评价。
Hum Reprod Update. 2010 Nov-Dec;16(6):651-74. doi: 10.1093/humupd/dmq009. Epub 2010 May 12.